Global Parkinson's Disease Therapeutics Sales Market Report 2022

Global Parkinson's Disease Therapeutics Sales Market Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size by Type (2017 VS 2021VS 2028)
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2017-2028)
2.2 Global Parkinson's Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.3 Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2017-2022)
2.4 Global Parkinson's Disease Therapeutics Revenue Forecast by Region (2023-2028)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Parkinson's Disease Therapeutics Estimates and Projections (2017-2028)
2.5.2 Europe Parkinson's Disease Therapeutics Estimates and Projections (2017-2028)
2.5.3 China Parkinson's Disease Therapeutics Estimates and Projections (2017-2028)
2.5.4 Japan Parkinson's Disease Therapeutics Estimates and Projections (2017-2028)
2.5.5 Southeast Asia Parkinson's Disease Therapeutics Estimates and Projections (2017-2028)
2.5.6 India Parkinson's Disease Therapeutics Estimates and Projections (2017-2028)
3 Global Parkinson's Disease Therapeutics Competition Landscape by Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2017-2022)
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2021
3.5 Parkinson's Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Parkinson's Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 United States Parkinson's Disease Therapeutics Market Facts & Figures
6.1 United States Parkinson's Disease Therapeutics Revenue by Company (2017-2022)
6.2 United States Parkinson's Disease Therapeutics Market Size by Type
6.2.1 United States Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
6.2.2 United States Parkinson's Disease Therapeutics Market Size by Type (2023-2028)
6.2.3 United States Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
6.3 United States Parkinson's Disease Therapeutics Market Size by Application
6.3.1 United States Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
6.3.2 United States Parkinson's Disease Therapeutics Market Size by Application (2023-2028)
6.3.3 United States Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
7 Europe Parkinson's Disease Therapeutics Market Facts & Figures
7.1 Europe Parkinson's Disease Therapeutics Revenue by Company (2017-2022)
7.2 Europe Parkinson's Disease Therapeutics Market Size by Type
7.2.1 Europe Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Parkinson's Disease Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
7.3 Europe Parkinson's Disease Therapeutics Market Size by Application
7.3.1 Europe Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Parkinson's Disease Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
8 China Parkinson's Disease Therapeutics Market Facts & Figures
8.1 China Parkinson's Disease Therapeutics Revenue by Company (2017-2022)
8.2 China Parkinson's Disease Therapeutics Market Size by Type
8.2.1 China Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
8.2.2 China Parkinson's Disease Therapeutics Market Size by Type (2023-2028)
8.2.3 China Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
8.3 China Parkinson's Disease Therapeutics Market Size by Application
8.3.1 China Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
8.3.2 China Parkinson's Disease Therapeutics Market Size by Application (2023-2028)
8.3.3 China Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
9 Japan Parkinson's Disease Therapeutics Market Facts & Figures
9.1 Japan Parkinson's Disease Therapeutics Revenue by Company (2017-2022)
9.2 Japan Parkinson's Disease Therapeutics Market Size by Type
9.2.1 Japan Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
9.2.2 Japan Parkinson's Disease Therapeutics Market Size by Type (2023-2028)
9.2.3 Japan Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
9.3 Japan Parkinson's Disease Therapeutics Market Size by Application
9.3.1 Japan Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
9.3.2 Japan Parkinson's Disease Therapeutics Market Size by Application (2023-2028)
9.3.3 Japan Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
10 Southeast Asia Parkinson's Disease Therapeutics Market Facts & Figures
10.1 Southeast Asia Parkinson's Disease Therapeutics Revenue by Company (2017-2022)
10.2 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type
10.2.1 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
10.2.2 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2023-2028)
10.2.3 Southeast Asia Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
10.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application
10.3.1 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
10.3.2 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2023-2028)
10.3.3 Southeast Asia Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
11 India Parkinson's Disease Therapeutics Market Facts & Figures
11.1 India Parkinson's Disease Therapeutics Revenue by Company (2017-2022)
11.2 India Parkinson's Disease Therapeutics Market Size by Type
11.2.1 India Parkinson's Disease Therapeutics Market Size by Type (2017-2022)
11.2.2 India Parkinson's Disease Therapeutics Market Size by Type (2023-2028)
11.2.3 India Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
11.3 India Parkinson's Disease Therapeutics Market Size by Application
11.3.1 India Parkinson's Disease Therapeutics Market Size by Application (2017-2022)
11.3.2 India Parkinson's Disease Therapeutics Market Size by Application (2023-2028)
11.3.3 India Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
12 Key Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Merck Business Overview
12.1.3 Merck Parkinson's Disease Therapeutics Introduction
12.1.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.1.5 Merck Recent Development
12.2 Akorn
12.2.1 Akorn Company Details
12.2.2 Akorn Business Overview
12.2.3 Akorn Parkinson's Disease Therapeutics Introduction
12.2.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.2.5 Akorn Recent Development
12.3 GSK
12.3.1 GSK Company Details
12.3.2 GSK Business Overview
12.3.3 GSK Parkinson's Disease Therapeutics Introduction
12.3.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.3.5 GSK Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Novartis Business Overview
12.4.3 Novartis Parkinson's Disease Therapeutics Introduction
12.4.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.4.5 Novartis Recent Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Company Details
12.5.2 Boehringer Ingelheim Business Overview
12.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
12.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.5.5 Boehringer Ingelheim Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Company Details
12.6.2 Teva Pharmaceutical Business Overview
12.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
12.6.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.6.5 Teva Pharmaceutical Recent Development
12.7 Abbvie
12.7.1 Abbvie Company Details
12.7.2 Abbvie Business Overview
12.7.3 Abbvie Parkinson's Disease Therapeutics Introduction
12.7.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.7.5 Abbvie Recent Development
12.8 Kyowa Hakko Kirin Pharma
12.8.1 Kyowa Hakko Kirin Pharma Company Details
12.8.2 Kyowa Hakko Kirin Pharma Business Overview
12.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
12.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.8.5 Kyowa Hakko Kirin Pharma Recent Development
12.9 Astellas Pharma
12.9.1 Astellas Pharma Company Details
12.9.2 Astellas Pharma Business Overview
12.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
12.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.9.5 Astellas Pharma Recent Development
12.10 Roche
12.10.1 Roche Company Details
12.10.2 Roche Business Overview
12.10.3 Roche Parkinson's Disease Therapeutics Introduction
12.10.4 Roche Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.10.5 Roche Recent Development
12.11 H.Lundbeck
12.11.1 H.Lundbeck Company Details
12.11.2 H.Lundbeck Business Overview
12.11.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
12.11.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.11.5 H.Lundbeck Recent Development
12.12 Bausch Health
12.12.1 Bausch Health Company Details
12.12.2 Bausch Health Business Overview
12.12.3 Bausch Health Parkinson's Disease Therapeutics Introduction
12.12.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.12.5 Bausch Health Recent Development
12.13 Apokyn
12.13.1 Apokyn Company Details
12.13.2 Apokyn Business Overview
12.13.3 Apokyn Parkinson's Disease Therapeutics Introduction
12.13.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.13.5 Apokyn Recent Development
12.14 Orion
12.14.1 Orion Company Details
12.14.2 Orion Business Overview
12.14.3 Orion Parkinson's Disease Therapeutics Introduction
12.14.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.14.5 Orion Recent Development
12.15 Stada Arzneimittel
12.15.1 Stada Arzneimittel Company Details
12.15.2 Stada Arzneimittel Business Overview
12.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
12.15.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.15.5 Stada Arzneimittel Recent Development
12.16 US WorldMeds
12.16.1 US WorldMeds Company Details
12.16.2 US WorldMeds Business Overview
12.16.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
12.16.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.16.5 US WorldMeds Recent Development
12.17 Desitin Arzneimittel
12.17.1 Desitin Arzneimittel Company Details
12.17.2 Desitin Arzneimittel Business Overview
12.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
12.17.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.17.5 Desitin Arzneimittel Recent Development
12.18 Endo Pharmaceuticals
12.18.1 Endo Pharmaceuticals Company Details
12.18.2 Endo Pharmaceuticals Business Overview
12.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
12.18.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2017-2022)
12.18.5 Endo Pharmaceuticals Recent Development
13 Market Dynamics
13.1 Parkinson's Disease Therapeutics Industry Trends
13.2 Parkinson's Disease Therapeutics Market Drivers
13.3 Parkinson's Disease Therapeutics Market Challenges
13.4 Parkinson's Disease Therapeutics Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million): (2017 VS 2021 VS 2028)
Table 2. Major Players of Sinemet-CR
Table 3. Major Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson's Disease Therapeutics Market Size Growth by Application (2017 VS 2021 VS 2028)
Table 8. Global Parkinson's Disease Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Parkinson's Disease Therapeutics Revenue (US$ Million) Market Share by Region (2017-2022))
Table 10. Global Parkinson's Disease Therapeutics Revenue Share by Region (2017-2022)
Table 11. Global Parkinson's Disease Therapeutics Revenue (US$ Million) Forecast by Region (2023-2028)
Table 12. Global Parkinson's Disease Therapeutics Revenue Share Forecast by Region (2023-2028)
Table 13. Global Parkinson's Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 14. Global Parkinson's Disease Therapeutics Revenue Share by Players (2017-2022)
Table 15. Global Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2021)
Table 16. Ranking of Global Top Parkinson's Disease Therapeutics Companies by Revenue (US$ Million) in 2021
Table 17. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Parkinson's Disease Therapeutics Product Solution and Service
Table 20. Date of Enter into Parkinson's Disease Therapeutics Market
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 23. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2017-2022)
Table 24. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 25. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2023-2028)
Table 26. Global Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2017-2022)
Table 28. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 29. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2023-2028)
Table 30. United States Parkinson's Disease Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 31. United States Parkinson's Disease Therapeutics Revenue Market Share by Company (2017-2022)
Table 32. United States Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & ()
Table 33. United States Parkinson's Disease Therapeutics Market Size by Type (2023-2028) & ()
Table 34. United States Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & ()
Table 35. United States Parkinson's Disease Therapeutics Market Size by Application (2023-2028) & ()
Table 36. Europe Parkinson's Disease Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 37. Europe Parkinson's Disease Therapeutics Revenue Market Share by Company (2017-2022)
Table 38. Europe Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Parkinson's Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Parkinson's Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. China Parkinson's Disease Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 43. China Parkinson's Disease Therapeutics Revenue Market Share by Company (2017-2022)
Table 44. China Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. China Parkinson's Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. China Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. China Parkinson's Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Japan Parkinson's Disease Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 49. Japan Parkinson's Disease Therapeutics Revenue Market Share by Company (2017-2022)
Table 50. Japan Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Japan Parkinson's Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Japan Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Japan Parkinson's Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Southeast Asia Parkinson's Disease Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 55. Southeast Asia Parkinson's Disease Therapeutics Revenue Market Share by Company (2017-2022)
Table 56. Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. India Parkinson's Disease Therapeutics Revenue by Company (2017-2022) & (US$ Million)
Table 61. India Parkinson's Disease Therapeutics Revenue Market Share by Company (2017-2022)
Table 62. India Parkinson's Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 63. India Parkinson's Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 64. India Parkinson's Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 65. India Parkinson's Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 66. Merck Company Details
Table 67. Merck Description and Business Overview
Table 68. Merck Parkinson's Disease Therapeutics Product
Table 69. Merck Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Akorn Company Details
Table 72. Akorn Description and Business Overview
Table 73. Akorn Parkinson's Disease Therapeutics Product
Table 74. Akorn Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Akorn Recent Development
Table 76. GSK Company Details
Table 77. GSK Description and Business Overview
Table 78. GSK Parkinson's Disease Therapeutics Product
Table 79. GSK Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 80. GSK Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Description and Business Overview
Table 83. Novartis Parkinson's Disease Therapeutics Product
Table 84. Novartis Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Description and Business Overview
Table 88. Boehringer Ingelheim Parkinson's Disease Therapeutics Product
Table 89. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Teva Pharmaceutical Company Details
Table 92. Teva Pharmaceutical Description and Business Overview
Table 93. Teva Pharmaceutical Parkinson's Disease Therapeutics Product
Table 94. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 95. Teva Pharmaceutical Recent Development
Table 96. Abbvie Company Details
Table 97. Abbvie Description and Business Overview
Table 98. Abbvie Parkinson's Disease Therapeutics Product
Table 99. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 100. Abbvie Recent Development
Table 101. Kyowa Hakko Kirin Pharma Company Details
Table 102. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product
Table 103. Kyowa Hakko Kirin Pharma Description and Business Overview
Table 104. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 105. Kyowa Hakko Kirin Pharma Recent Development
Table 106. Astellas Pharma Company Details
Table 107. Astellas Pharma Parkinson's Disease Therapeutics Product
Table 108. Astellas Pharma Description and Business Overview
Table 109. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 110. Astellas Pharma Recent Development
Table 111. Roche Company Details
Table 112. Roche Description and Business Overview
Table 113. Roche Parkinson's Disease Therapeutics Product
Table 114. Roche Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 115. Roche Recent Development
Table 116. H.Lundbeck Company Details
Table 117. H.Lundbeck Description and Business Overview
Table 118. H.Lundbeck Parkinson's Disease Therapeutics Product
Table 119. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 120. H.Lundbeck Recent Development
Table 121. Bausch Health Company Details
Table 122. Bausch Health Description and Business Overview
Table 123. Bausch Health Parkinson's Disease Therapeutics Product
Table 124. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 125. Bausch Health Recent Development
Table 126. Apokyn Company Details
Table 127. Apokyn Description and Business Overview
Table 128. Apokyn Parkinson's Disease Therapeutics Product
Table 129. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 130. Apokyn Recent Development
Table 131. Orion Company Details
Table 132. Orion Description and Business Overview
Table 133. Orion Parkinson's Disease Therapeutics Product
Table 134. Orion Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 135. Orion Recent Development
Table 136. Stada Arzneimittel Company Details
Table 137. Stada Arzneimittel Description and Business Overview
Table 138. Stada Arzneimittel Parkinson's Disease Therapeutics Product
Table 139. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 140. Stada Arzneimittel Recent Development
Table 141. US WorldMeds Company Details
Table 142. US WorldMeds Description and Business Overview
Table 143. US WorldMeds Parkinson's Disease Therapeutics Product
Table 144. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 145. US WorldMeds Recent Development
Table 146. Desitin Arzneimittel Company Details
Table 147. Desitin Arzneimittel Description and Business Overview
Table 148. Desitin Arzneimittel Parkinson's Disease Therapeutics Product
Table 149. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 150. Desitin Arzneimittel Recent Development
Table 151. Endo Pharmaceuticals Company Details
Table 152. Endo Pharmaceuticals Description and Business Overview
Table 153. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product
Table 154. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 155. Endo Pharmaceuticals Recent Development
Table 156. Parkinson's Disease Therapeutics Market Trends
Table 157. Parkinson's Disease Therapeutics Market Drivers
Table 158. Parkinson's Disease Therapeutics Market Challenges
Table 159. Parkinson's Disease Therapeutics Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Sinemet-CR Features
Figure 3. Trastal Features
Figure 4. Madopar Features
Figure 5. COMT Inhibitor Features
Figure 6. Other Features
Figure 7. Global Parkinson's Disease Therapeutics Market Share by Application: 2021 VS 2028
Figure 8. Under 40 Years Old Case Studies
Figure 9. 40-65 Years Old Case Studies
Figure 10. Above 65 Years Old Case Studies
Figure 11. Parkinson's Disease Therapeutics Report Years Considered
Figure 12. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Parkinson's Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Parkinson's Disease Therapeutics Revenue Market Share by Region: 2017 VS 2021
Figure 15. United States Parkinson's Disease Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 16. Europe Parkinson's Disease Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 17. China Parkinson's Disease Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 18. Japan Parkinson's Disease Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 19. Southeast Asia Parkinson's Disease Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 20. India Parkinson's Disease Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
Figure 21. Global Parkinson's Disease Therapeutics Market Share by Players in 2021
Figure 22. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2021)
Figure 23. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2021
Figure 24. United States Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
Figure 25. United States Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
Figure 26. Europe Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
Figure 27. Europe Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
Figure 28. China Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
Figure 29. China Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
Figure 30. Japan Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
Figure 31. Japan Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
Figure 32. Southeast Asia Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
Figure 33. Southeast Asia Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
Figure 34. India Parkinson's Disease Therapeutics Market Share by Type (2017-2028)
Figure 35. India Parkinson's Disease Therapeutics Market Share by Application (2017-2028)
Figure 36. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 37. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 38. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 39. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 40. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 41. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 42. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 43. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 44. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 45. Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 46. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 47. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 48. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 49. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 50. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 51. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 52. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 53. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2017-2022)
Figure 54. Bottom-up and Top-down Ap

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs